Targeting Hidden Pathogens: Cell-Penetrating Enzybiotics Eradicate Intracellular Drug-Resistant Staphylococcus aureus
Christian Röhrig, Markus Huemer, Dominique Lorgé, Samuel Luterbacher, Preeda Phothaworn, Christopher Schefer, Anna M. Sobieraj, Léa V. Zinsli, Srikanth Mairpady Shambat, Nadja Leimer, Anja Keller, Fritz Eichenseher, Yang Shen, Sunee Korbsrisate, Annelies S. Zinkernagel, Martin J. Loessner, Mathias Schmelcher
Abstract
The increasing prevalence of antibiotic-resistant bacteria is one of the most urgent problems of our time. Staphylococcus aureus is an important human pathogen that has acquired several mechanisms to evade antibiotic treatment. In addition, S. aureus is able to invade and persist within human cells, hiding from the immune response and antibiotic therapies. For these reasons, novel antibacterial strategies against these pathogens are needed. Here, we developed lytic enzymes which are able to effectively target drug-resistant and intracellular S. aureus . Fusion of these so-called enzybiotics to cell-penetrating peptides enhanced their uptake and intracellular bactericidal activity in cell culture and in an abscess mouse model. Our results suggest that cell-penetrating enzybiotics are a promising new class of therapeutics against staphylococcal infections.